Lexaria CEO Chris Bunka on the Latest Cannabinoid Patents With Big Potential Revenue Streams

2,187 views · Published 2 February 2018 · 6:54 · Indexed 3 October 2026

Channel: Midas Letter · 2018 · Education

Watch on YouTube

Lexaria Bioscience Corp (CNSX:LXX) (OTCMKTS:LXRP) 
is a drug delivery platform innovator. CEO Chris Bunka talks about the company's new patent which covers new cannabinoids and other ingestible molecules delivery platform, as well as its DehydraTECH™ technology, which improves tastes and the rapidity in which a drug reaches your blood stream. The nicotine space is seen as one of the biggest opportunities for Lexaria products.

************************
LINK: http://bit.ly/LexariaPatent

************************

Check out our website: 
https://MidasLetter.com

************************

SUBSCRIBE to our YouTube: 
http://bit.ly/MidasLetterYoutube 

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter 

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter: 
http://bit.ly/MidasLetterTwitter

Like Us on Instagram: 
http://bit.ly/MidasLetterInsta 

Like Us on Facebook: 
http://bit.ly/MidasLetterFacebook

************************

More from this channel